These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2868341)

  • 1. Moderate doses of aspirin and risk of bleeding in renal failure.
    Livio M; Benigni A; Viganò G; Mecca G; Remuzzi G
    Lancet; 1986 Feb; 1(8478):414-6. PubMed ID: 2868341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet disorders in uraemia before and after haemodialysis under the influence of low dose aspirin.
    Tschugguel W; Blaicher A; Kramer L; Felfernig M; Jüngling G; Kurz M; Gnant M; Zimpfer M
    Thromb Res; 1995 Nov; 80(3):225-33. PubMed ID: 8578549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of uraemic bleeding with conjugated oestrogen.
    Liu YK; Kosfeld RE; Marcum SG
    Lancet; 1984 Oct; 2(8408):887-90. PubMed ID: 6148618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Clot Signature Analyzer as a hemostasis test in healthy volunteers exposed to low doses of aspirin.
    Igawa T; Kornhauser R; Cilla DD; King JO; Kambayashi J
    Clin Appl Thromb Hemost; 1999 Apr; 5(2):117-21. PubMed ID: 10725992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis.
    Remuzzi G; Livio M; Marchiaro G; Mecca G; de Gaetano G
    Nephron; 1978; 22(4-6):347-53. PubMed ID: 740096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative administration of a single dose of conjugated oestrogen to uraemic patients is ineffective in improving haemostasis.
    Jacobs P; Jacobson J; Kahn D
    Am J Hematol; 1994 May; 46(1):24-8. PubMed ID: 8184873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperparathyroidism does not influence the abnormal primary haemostasis in patients with chronic renal failure.
    Viganò G; Gotti E; Comberti E; Giangrande A; Trevisan R; Remuzzi G
    Nephrol Dial Transplant; 1989; 4(11):971-4. PubMed ID: 2516889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
    Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
    Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions.
    Fernandez F; Goudable C; Sie P; Ton-That H; Durand D; Suc JM; Boneu B
    Br J Haematol; 1985 Jan; 59(1):139-48. PubMed ID: 3918557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin and risk of bleeding in patients with thrombocythemia.
    Barbui T; Buelli M; Cortelazzo S; Viero P; De Gaetano G
    Am J Med; 1987 Aug; 83(2):265-8. PubMed ID: 3497579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin and spontaneous platelet aggregation in haemodialysis patients.
    Taylor JE; Henderson IS; Stewart WK; Belch JJ
    Lancet; 1991 Nov; 338(8779):1361-2. PubMed ID: 1682739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired expression of glycoproteins on resting and stimulated platelets in uraemic patients.
    Moal V; Brunet P; Dou L; Morange S; Sampol J; Berland Y
    Nephrol Dial Transplant; 2003 Sep; 18(9):1834-41. PubMed ID: 12937232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time related neutralization of two doses acetyl salicylic acid.
    Aguejouf O; Malfatti E; Belon P; Doutremepuich C
    Thromb Res; 2000 Nov; 100(4):317-23. PubMed ID: 11113275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy.
    Grüner S; Prostredna M; Aktas B; Moers A; Schulte V; Krieg T; Offermanns S; Eckes B; Nieswandt B
    Circulation; 2004 Nov; 110(18):2946-51. PubMed ID: 15505105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: beyond aspirin and clopidogrel.
    Cohen MG; Rossi JS; Garbarino J; Bowling R; Motsinger-Reif AA; Schuler C; Dupont AG; Gabriel D
    Thromb Res; 2011 Oct; 128(4):335-40. PubMed ID: 21621252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding in renal failure: is von Willebrand factor implicated?
    Remuzzi G; Livio M; Roncaglioni MC; Mecca G; Donati MB; de Gaetano G
    Br Med J; 1977 Aug; 2(6083):359-61. PubMed ID: 302134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of aspirin induced changes in bleeding time, platelet aggregation, and Sonoclot coagulation analysis in humans.
    Samra SK; Harrison RL; Bee DE; Valero V
    Ann Clin Lab Sci; 1991; 21(5):315-27. PubMed ID: 1952780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding in renal failure.
    Remuzzi G
    Lancet; 1988 May; 1(8596):1205-8. PubMed ID: 2897015
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
    Preston FE; Whipps S; Jackson CA; French AJ; Wyld PJ; Stoddard CJ
    N Engl J Med; 1981 Jan; 304(2):76-9. PubMed ID: 7003384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on mechanisms of a haemostatic effect of 1 deamino-8-D-arginine vasopressin (desmopressin) in uraemic patients.
    Malyszko J; Pietraszek M; Buczko W; Mysliwiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):319-24. PubMed ID: 1697836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.